Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Novo Nordisk headquarters

New product can overtake Lantus, says Novo leader

May 11, 2011
Sales and Marketing Novo Nordisk, degludec, diabetes, insulin

Novo Nordisk’s new insulin product can eclipse Sanofi’s Lantus within just a few years of its launch, according to Novo’s …

News
Sanofi headquarters

Sanofi abandons $375m oral diabetes deal

May 9, 2011
Sales and Marketing Metabolex, Sanofi, diabetes

Sanofi has terminated its $375 million deal with US biotech Metabolex to develop a novel oral anti-diabetic treatment. The French …

News

US approval for Boehringer’s diabetes drug Tradjenta

May 3, 2011
Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly

Tradjenta, the once-daily oral type II diabetes treatment developed by Boehringer Ingelheim, has been approved by US regulators. The FDA …

News

Diabetes trial disappointment for GSK and Tolerx

March 14, 2011
Research and Development DEFEND-1, DEFEND-2, GSK, GlaxoSmithKline, Tolerx, diabetes, otelixizumab, type I diabetes

GSK and Tolerx’s type I diabetes drug otelixizumab has failed to meet its primary endpoint in a late-stage trial. Anti-CD3 …

News
Novo Nordisk's Victoza

Novo’s Victoza beats Bydureon in head-to-head trial

March 4, 2011
Research and Development, Sales and Marketing Alkermes, Amylin, Byureon, Victoza, diabetes, exenatide, lilly, type II diabetes

Bydureon has been outperformed by rival Victoza in a head-to-trial, decimating shares in its co-developer Amylin and Alkermes, the company …

News

Onglyza expands European licence

March 4, 2011
Sales and Marketing AZ, AstraZeneca, BMS, Bristol-Myers Squibb, Onglyza, diabetes, renal impairment, saxagliptin, type II diabetes

European regulators have approved a licence extension for diabetes treatment Onglyza, making it the first drug in its class that …

News
Sanofi's VTE avatar

Digital Pharma: online campaign directory updated

March 4, 2011
Medical Communications, Sales and Marketing Digital Pharma blog, Novartis, Pfizer, Sanofi-Aventis, VTE, diabetes, erectile dysfunction, pharmacist educaiton, venous thromboembolism, viagra

The latest update to the Digital Pharma links directory covers its online campaigns section and includes a pharmacist networking portal …

Feature

Sanofi picks two agencies for UK diabetes account

February 25, 2011
Medical Communications Lantus, Sanofi-Aventis, Tudor Reilly, diabetes, medical communications account win, red health

Healthcare PR agencies Tudor Reilly and Red Health have jointly won the Sanofi-Aventis UK diabetes account after a five-way pitch. …

News

Diabetes success for Sanofi, disappointment for Roche

February 2, 2011
Roche, Sanofi, diabetes

The contrasting fortunes of two new diabetes became clear today, with Sanofi-Aventis lixisenatide performing well, as Roche abandoned taspoglutide.Sanofi’s lixisenatide, …

News

GSK settles Avandia case out of court

February 1, 2011
Sales and Marketing Avandia, GSK, diabetes

GlaxoSmithKline this week settled a US federal lawsuit regarding its diabetes drug Avandia before it went to court. The company …

News
Blog footer

Digital Pharma: Sanofi launches diabetes blog

January 17, 2011
Medical Communications, Sales and Marketing Digital Pharma blog, Sanofi-Aventis, blog, diabetes

Sanofi-Aventis has ramped up its social media efforts with the launch of a blog about diabetes for US consumers. The …

News
Novo Nordisk's Victoza

Diabetes drugs show promise in Alzheimer’s

January 17, 2011
Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …

News

Lilly and Boehringer sign major diabetes collaboration

January 12, 2011
Research and Development BI10773, Boehringer Ingelheim, Eli Lilly, LY2605541, LY2963016, TGF-beta monoclonal antibody, diabetes, lilly, linagliptin, type II diabetes

Eli Lilly and Boehringer Ingelheim have signed a multi-million dollar collaboration that will see them develop and commercialise a mid- …

News

Novo to develop oral insulin

December 22, 2010
Research and Development Emisphere, Novo Nordisk, diabetes, insulin, oral insulin, type I diabetes

Novo Nordisk is to develop an oral formulation of insulin with US biotech company Emisphere Technologies. The New Jersey-based biotech …

News
ABPI

Novo rebuked after diabetes promotion breaches Code

December 16, 2010
Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly

Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026